# Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

> **NCT03607955** · PHASE1 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Epithelial Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Cancer

## Interventions

- **DRUG:** AVB-S6-500
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **PROCEDURE:** Tissue from Diagnostic Laparoscopy
- **PROCEDURE:** Tissue from Core biopsy
- **PROCEDURE:** Interval Debulking
- **PROCEDURE:** Peripheral blood
- **PROCEDURE:** Ascites collection

## Key facts

- **NCT ID:** NCT03607955
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-30
- **Primary completion:** 2024-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Trial may move forward as an NCI-sponsored trial and not an investigator initiated trial.
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607955, "Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03607955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*